Undiagnosed Cases of Human Pneumonia Following Exposure to Chlamydia psittaci from an Infected Rosella Parrot

Anne-Lise Chaber1, Martina Jelocnik2, Lucy Woolford1

  • 1School of Animal and Veterinary Science, University of Adelaide, Roseworthy, SA 5371, Australia.

Insights

Two individuals contracted Chlamydia psittaci (psittacosis) after handling an infected Rosella parrot. This zoonotic disease may be underdiagnosed, highlighting the need for better awareness and diagnostic practices.

Area of Science:

  • Zoonotic disease transmission
  • Occupational health and safety
  • Veterinary pathology

Background:

  • Chlamydia psittaci is a zoonotic pathogen that can cause psittacosis in humans.
  • Occupational exposure to avian species poses a risk for psittacosis transmission.
  • Underreporting of psittacosis may occur due to diagnostic challenges.

Observation:

  • Two cases of occupational Chlamydia psittaci infection occurred after dissecting an infected Rosella parrot.
  • Initial medical investigations failed to diagnose the C. psittaci infections.
  • Epidemiological, clinical, and molecular evidence confirmed the diagnoses, including pneumonia and hospitalization in one case.

Findings:

  • Chlamydia psittaci infections were confirmed through molecular testing of avian specimens.
  • The cases highlight potential misdiagnosis of psittacosis in individuals exposed to infected birds.
  • Psittacosis is likely underreported in Australia, necessitating improved diagnostic approaches.

Implications:

  • Accurate diagnostic test application and interpretation are crucial for identifying zoonotic diseases.
  • Increased awareness of psittacosis among medical practitioners and exposed individuals is vital.
  • Operationalizing the One Health concept and enhancing inter-professional communication are essential for managing zoonotic risks.

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
181
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
422
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
529
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.1K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
493
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
511